{
    "nctId": "NCT00002455",
    "briefTitle": "Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma",
    "officialTitle": "Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Colorectal Cancer, Melanoma (Skin)",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "N/A",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": "N/A",
    "primaryOutcomeMeasure": "Recurrence",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of colon cancer, breast cancer, or melanoma with minimal residual disease (at least 90% of tumor mass resected) after surgical resection\n* Hormone receptor status:\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\nAge:\n\n* 20 to 80\n\nSex:\n\n* Not specified\n\nMenopausal status:\n\n* Not specified\n\nPerformance status:\n\n* Not specified\n\nLife expectancy:\n\n* Not specified\n\nHematopoietic:\n\n* Not specified\n\nHepatic:\n\n* Not specified\n\nRenal:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* Not specified\n\nChemotherapy\n\n* Not specified\n\nEndocrine therapy\n\n* Not specified\n\nRadiotherapy\n\n* Not specified\n\nSurgery\n\n* See Disease Characteristics",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}